Severe Combined Immunodeficiency, X Linked
Immunology·MeSH: Basal ganglia disease, biotin-responsive
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Severe Combined Immunodeficiency, X Linked?
There are 1 clinical trial targeting Severe Combined Immunodeficiency, X Linked tracked by BioSniper.
What is the prevalence of Severe Combined Immunodeficiency, X Linked?
The estimated prevalence of Severe Combined Immunodeficiency, X Linked is approximately 5.0 per 100,000 population.
Deep-dive into Severe Combined Immunodeficiency, X Linked
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis